{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:18:16Z","timestamp":1782793096132,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1124\/dmd.108.023408","type":"journal-article","created":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T00:33:57Z","timestamp":1224549237000},"page":"161-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Structural Modulation of Oxidative Metabolism in Design of Improved Benzothiophene Selective Estrogen Receptor Modulators"],"prefix":"10.1016","volume":"37","author":[{"given":"Zhihui","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irida","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezene T.","family":"Ashgodom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Lantvit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassia R.","family":"Overk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsoo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"van Breemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy L.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.J.","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.023408_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.108.023408_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1124\/dmd.108.023408_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"Bolton","year":"2000","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.023408_bib4","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0090-8258(03)00343-3","article-title":"Arzoxifene as therapy for endometrial cancer","volume":"90","author":"Burke","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1124\/dmd.108.023408_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2003.06.108","article-title":"Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer","volume":"21","author":"Buzdar","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.108.023408_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00130404-200301000-00003","article-title":"Current status of selective estrogen receptor modulators (SERMs)","volume":"9","author":"Conzen","year":"2003","journal-title":"Cancer J"},{"key":"10.1124\/dmd.108.023408_bib7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.108.023408_bib8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1021\/tx060126v","article-title":"Bioactivation of selective estrogen receptor modulators (SERMs)","volume":"19","author":"Dowers","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.023408_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/03602539608994017","article-title":"QSAR of P450 oxidation: on the value of comparing kcat and Km with kcat\/Km","volume":"28","author":"Gao","year":"1996","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.108.023408_bib10","series-title":"Exploring QSAR.","author":"Hansch","year":"1995"},{"key":"10.1124\/dmd.108.023408_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03602539308993972","article-title":"Quantitative structure-activity relationships of cytochrome P-450","volume":"25","author":"Hansch","year":"1993","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.108.023408_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0301-2115(98)00278-4","article-title":"Pharmacokinetics of raloxifene and its clinical application","volume":"85","author":"Hochner-Celnikier","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1124\/dmd.108.023408_bib13","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1021\/jm050723z","article-title":"A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats","volume":"48","author":"Hummel","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.108.023408_bib14","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/dmd.108.023408_bib15","first-page":"209","article-title":"The study of tamoxifen and raloxifene (STAR trial) for the prevention of breast cancer","volume":"61","author":"Kelminski","year":"2002","journal-title":"Hawaii Med J"},{"key":"10.1124\/dmd.108.023408_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/dmd.30.6.694","article-title":"Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance","volume":"30","author":"Kemp","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.023408_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1359-6446(04)03115-0","article-title":"Compound lipophilicity for substrate binding to human P450s in drug metabolism","volume":"9","author":"Lewis","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1124\/dmd.108.023408_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0026-895X(25)12551-0","article-title":"Catechol formation of fluoro- and bromo-substituted estradiols by hamster liver microsomes: evidence for dehalogenation","volume":"27","author":"Li","year":"1985","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.108.023408_bib19","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1158\/1078-0432.CCR-06-1119","article-title":"The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer","volume":"12","author":"Liby","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.108.023408_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0026-895X(25)14289-2","article-title":"2-Fluoroestradiol: separation of estrogenicity from carcinogenicity","volume":"23","author":"Liehr","year":"1983","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.108.023408_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00346049","article-title":"Modulation of estrogen-induced carcinogenesis by chemical modifications","volume":"55","author":"Liehr","year":"1984","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.108.023408_bib22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/tx050326r","article-title":"Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4\u2032F-DMA, a new benzothiophene selective estrogen receptor modulator","volume":"19","author":"Liu","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.023408_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/tx049776u","article-title":"Bioactivation of the selective estrogen receptor modulator desmethylated arzoxifene to quinoids: 4\u2032-fluoro substitution prevents quinoid formation","volume":"18","author":"Liu","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.023408_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1021\/tx0497752","article-title":"Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides","volume":"18","author":"Liu","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.108.023408_bib25","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/cmdc.200700104","article-title":"Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene","volume":"2","author":"Overk","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1124\/dmd.108.023408_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1021\/jm970167b","article-title":"Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]benzo[ b ]thiophene: a novel, highly potent, selective estrogen receptor modulator","volume":"40","author":"Palkowitz","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.108.023408_bib27","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1021\/jm070079j","article-title":"Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity","volume":"50","author":"Qin","year":"2007","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.108.023408_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1124\/dmd.108.023408_bib29","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1289\/ehp.971051204","article-title":"Estimating xenobiotic half-lives in humans from rat data: influence of log P","volume":"105","author":"Sarver","year":"1997","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.108.023408_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)37755-9","article-title":"LY353381 \u00b7 HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo","volume":"287","author":"Sato","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.023408_bib31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/carcin\/21.8.1461","article-title":"Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen","volume":"21","author":"Shibutani","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.108.023408_bib32","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/ajhp\/57.18.1669","article-title":"Raloxifene hydrochloride","volume":"57","author":"Snyder","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"10.1124\/dmd.108.023408_bib33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0026-895X(25)10598-1","article-title":"Catecholestrogens as mediators of carcinogenesis: correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in Syrian hamsters","volume":"45","author":"Stalford","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.108.023408_bib34","first-page":"8412","article-title":"Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer","volume":"61","author":"Suh","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.108.023408_bib35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","article-title":"Risk of endometrial cancer after tamoxifen treatment of breast cancer","volume":"343","author":"van Leeuwen","year":"1994","journal-title":"Lancet"},{"key":"10.1124\/dmd.108.023408_bib36","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1124\/dmd.108.023408_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.pa.36.040196.001223","article-title":"Molecular mechanisms of estrogen carcinogenesis","volume":"36","author":"Yager","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.108.023408_bib38","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/1535-7163.MCT-07-0268","article-title":"Structural modulation of reactivity\/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms","volume":"6","author":"Yu","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.108.023408_bib39","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/tx0342722","article-title":"Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones","volume":"17","author":"Yu","year":"2004","journal-title":"Chem Res Toxicol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624019160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624019160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.023408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:34:08Z","timestamp":1739896448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624019160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0090955624019160"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.023408","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Modulation of Oxidative Metabolism in Design of Improved Benzothiophene Selective Estrogen Receptor Modulators","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.023408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}